Euromedis Groupe (ALEMG.PA)
EUR 3.58
(0.28%)
EUR 3.58
(0.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 37.42 Million EUR | -30.92% |
| 2022 | 54.18 Million EUR | -51.58% |
| 2021 | 111.9 Million EUR | -42.14% |
| 2020 | 193.4 Million EUR | 150.91% |
| 2019 | 77.08 Million EUR | 1.35% |
| 2018 | 76.05 Million EUR | 3.34% |
| 2017 | 73.6 Million EUR | 0.6% |
| 2016 | 73.16 Million EUR | 2.77% |
| 2015 | 71.19 Million EUR | -2.67% |
| 2014 | 73.14 Million EUR | -3.34% |
| 2013 | 75.67 Million EUR | 1.75% |
| 2012 | 74.36 Million EUR | 12.92% |
| 2011 | 65.85 Million EUR | 2.65% |
| 2010 | 64.15 Million EUR | -0.09% |
| 2009 | 64.21 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 18.26 Million EUR | 0.0% |
| 2023 Q4 | 6.37 Million EUR | 0.0% |
| 2023 Q3 | 6.37 Million EUR | -74.2% |
| 2023 Q2 | 24.68 Million EUR | 100.0% |
| 2023 Q1 | 12.34 Million EUR | -50.33% |
| 2023 FY | 37.42 Million EUR | -30.92% |
| 2022 FY | 54.18 Million EUR | -51.58% |
| 2022 Q1 | 14.66 Million EUR | -63.33% |
| 2022 Q2 | 29.32 Million EUR | 100.0% |
| 2022 Q3 | 12.42 Million EUR | -57.63% |
| 2022 Q4 | 24.85 Million EUR | 99.99% |
| 2021 FY | 111.9 Million EUR | -42.14% |
| 2021 Q1 | 35.95 Million EUR | -72.75% |
| 2021 Q2 | 71.91 Million EUR | 100.0% |
| 2021 Q3 | 19.99 Million EUR | -72.2% |
| 2021 Q4 | 39.98 Million EUR | 100.0% |
| 2020 FY | 193.4 Million EUR | 150.91% |
| 2020 Q1 | 30.76 Million EUR | -20.52% |
| 2020 Q2 | 61.45 Million EUR | 99.79% |
| 2020 Q3 | 65.93 Million EUR | 7.29% |
| 2020 Q4 | 131.94 Million EUR | 100.11% |
| 2019 Q3 | 19.36 Million EUR | -49.55% |
| 2019 Q4 | 38.7 Million EUR | 99.88% |
| 2019 Q1 | 19.2 Million EUR | 0.0% |
| 2019 FY | 77.08 Million EUR | 1.35% |
| 2019 Q2 | 38.38 Million EUR | 99.85% |
| 2018 FY | 76.05 Million EUR | 3.34% |
| 2017 Q2 | 18.41 Million EUR | 0.0% |
| 2017 FY | 73.6 Million EUR | 0.6% |
| 2017 Q4 | 19.59 Million EUR | 0.0% |
| 2017 Q3 | 19.59 Million EUR | 6.41% |
| 2017 Q1 | 18.41 Million EUR | 0.14% |
| 2016 Q2 | 18.83 Million EUR | 0.0% |
| 2016 FY | 73.16 Million EUR | 2.77% |
| 2016 Q4 | 18.38 Million EUR | 0.0% |
| 2016 Q1 | 18.83 Million EUR | 4.44% |
| 2016 Q3 | 18.38 Million EUR | -2.38% |
| 2015 Q4 | 18.03 Million EUR | 0.0% |
| 2015 Q3 | 18.03 Million EUR | -0.39% |
| 2015 Q2 | 18.1 Million EUR | 0.0% |
| 2015 FY | 71.19 Million EUR | -2.67% |
| 2015 Q1 | 18.1 Million EUR | 1.72% |
| 2014 Q1 | 17.71 Million EUR | -3.67% |
| 2014 Q4 | 17.79 Million EUR | 0.0% |
| 2014 Q3 | 17.79 Million EUR | 0.45% |
| 2014 FY | 73.14 Million EUR | -3.34% |
| 2014 Q2 | 17.71 Million EUR | 0.0% |
| 2013 Q1 | 19 Million EUR | -0.61% |
| 2013 Q3 | 18.39 Million EUR | -3.21% |
| 2013 Q4 | 18.39 Million EUR | 0.0% |
| 2013 FY | 75.67 Million EUR | 1.75% |
| 2013 Q2 | 19 Million EUR | 0.0% |
| 2012 Q4 | 19.12 Million EUR | 0.0% |
| 2012 Q2 | 19.06 Million EUR | 0.0% |
| 2012 FY | 74.36 Million EUR | 12.92% |
| 2012 Q1 | 19.06 Million EUR | 2.97% |
| 2012 Q3 | 19.12 Million EUR | 0.3% |
| 2011 Q4 | 18.51 Million EUR | 0.0% |
| 2011 Q3 | 18.51 Million EUR | 0.0% |
| 2011 FY | 65.85 Million EUR | 2.65% |
| 2010 FY | 64.15 Million EUR | -0.09% |
| 2009 FY | 64.21 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Affluent Medical SA | 1.22 Million EUR | -2957.896% |
| Bluelinea Société Anonyme | 9826.00 EUR | -380814.37% |
| Carmat SA | 2.84 Million EUR | -1214.208% |
| Diagnostic Medical Systems S.A. | 42.15 Million EUR | 11.208% |
| Eurobio Scientific Société anonyme | 130.64 Million EUR | 71.351% |
| Ikonisys S.A. | 448.55 Thousand EUR | -8244.234% |
| Implanet S.A. | 7.44 Million EUR | -402.6% |
| Median Technologies SA | 22.22 Million EUR | -68.4% |
| SpineGuard SA | 4.31 Million EUR | -767.851% |
| Theraclion SA | 1.82 Million EUR | -1954.012% |
| Euroapi S.A. | 1.01 Billion EUR | 96.327% |
| Guerbet SA | 785.69 Million EUR | 95.236% |